NSNaeha Subramanian

Naeha Subramanian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Naeha Subramanian has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multiomics Reveals Compartmentalized Immune Responses and Tissue-Vascular Signatures in Lyme Disease

    by Clifford Rostomily, Ameek Bhalla, Henry Hampton, Lance Pflieger, Mary E. Brunkow, Denise Cooper, Christopher Lausted, Ajay Suresh Akhade, Brett Smith, Kelsey Scherler, et al.

    Lyme disease (LD) is growing in incidence, with nearly 500,000 cases diagnosed annually in the United States. Despite treatment, some patients experience persistent symptoms. The immune mechanisms underlying LD remain poorly understood. We conducted a multiomic longitudinal analysis of 49 LD patients and matched controls, integrating plasma proteomics, metabolomics, PBMC immunophenotyping, and a meta-analysis of skin lesions. We identified compartmentalized immune responses in acute LD, with coordinated alterations in circulating plasma proteins and metabolites linked to endothelial barrier stability, metabolic reprogramming, and symptom severity, predominantly traced to tissue and vascular immune processes at the site of infection. In contrast, PBMCs remained largely quiescent, revealing a disconnect between localized tissue responses and systemic immunity. These findings provide novel insights into LD pathophysiology and highlight the potential for diagnostics leveraging tissue and vascular immune markers detectable in blood. They also provide a resource for biomarker discovery and predictive modeling to improve LD management.

  • Open Access

    Revealing the dance of NLRP3: spatiotemporal patterns in inflammasome activation

    by Lauren Spector, Naeha Subramanian

    The nucleotide-binding domain, leucine-rich repeat, and pyrin domain containing-protein 3 (NLRP3) inflammasome is a multiprotein complex that plays a critical role in the innate immune response to both infections and sterile stressors. Dysregulated NLRP3 activation has been implicated in a variety of autoimmune and inflammatory diseases, including cryopyrin-associated periodic fever syndromes, diabetes, atherosclerosis, Alzheimer’s disease, inflammatory bowel disease, and cancer. Consequently, fine-tuning NLRP3 activity holds significant therapeutic potential. Studies have implicated several organelles, including mitochondria, lysosomes, the endoplasmic reticulum (ER), the Golgi apparatus, endosomes, and the centrosome, in NLRP3 localization and inflammasome assembly. However, reports of conflict and many factors regulating interactions between NLRP3 and subcellular organelles remain unknown. This review synthesizes the current understanding of NLRP3 spatiotemporal dynamics, focusing on recent literature that elucidates the roles of subcellular localization and organelle stress in NLRP3 signaling and its crosstalk with other innate immune pathways converging at these organelles.


  • Lentivirus-mediated Conditional Gene Expression

    by Leah Rommereim, Ajay Suresh Akhade, Ronald N. Germain, Iain D. C. Fraser, Naeha Subramanian

    The ability to identify the role of a particular gene within a system is dependent on control of the expression of that gene. In this protocol, we describe a method for stable, conditional expression of Nod-Like receptors (NLRs) in THP-1 cells using a lentiviral expression system. This system combines all the necessary components for tetracycline-inducible gene expression in a single lentivector with constitutive co-expression of a selection marker, which is an efficient means for controlling gene expression using a single viral infection of cells. This is done in a third generation lentiviral expression platform that improves the safety of lentiviruses and allows for greater gene expression than previous lentiviral platforms. The lentiviral expression plasmid is first engineered to contain the gene of interest driven by a TRE (tetracycline response element) promoter in a simple gateway cloning step and is then co-transfected into HEK293T cells, along with packaging and envelope plasmids to generate the virus. The virus is used to infect a cell type of interest at a low MOI so that the majority of the transduced cells contain a single viral integration. Infected cells are grown under selection, and viral integration is validated by qPCR. Gene expression in stably transduced cells is induced with doxycycline and validated by qPCR, immunoblot, and flow cytometry. This flexible lentiviral expression platform may be used for stable and robust induction of a gene of interest in a range of cells for multiple applications.Graphic Schematic overview of lentiviral transduction of THP-1 cells., [摘要]识别系统内特定基因作用的能力取决于对该基因的表达。在这个协议中,我们描述了一种稳定的条件表达方法使用慢病毒表达系统的 THP-1 细胞中的 Nod 样受体 (NLR)。该系统结合四环素诱导基因在单个慢载体中表达的所有必要成分选择标记的组成型共表达,这是控制基因的有效手段使用细胞的单一病毒感染来表达。这是在第三代慢病毒表达中完成的提高慢病毒安全性并允许比以前更高的基因表达的平台慢病毒平台。慢病毒表达质粒首先被设计为包含感兴趣的基因在简单的网关克隆步骤中由 TRE(四环素反应元件)启动子驱动,然后与包装和包膜质粒共转染到 HEK293T 细胞中以产生病毒。该病毒用于以低 MOI 感染感兴趣的细胞类型,以便大多数转导细胞包含单个病毒整合。受感染的细胞在选择下生长,病毒整合是通过 qPCR 验证。稳定转导细胞中的基因表达由强力霉素和通过 qPCR、免疫印迹和流式细胞术验证。这种灵活的慢病毒表达平台可能是用于在一系列细胞中稳定和稳健地诱导感兴趣的基因,以用于多种应用。图文摘要:THP-1 细胞慢病毒转导示意图。关键词: NLR,NOD1,慢病毒,稳定表达,TRE,四环素[背景]在分子生物学中研究功能反应的一项关键技术是来调节基因的表达。组成型基因表达系统允许研究人员只有在长期过表达无毒的情况下才能探索基因反应。这样的系统也可以导致细胞内代偿机制的发展,可以掩盖功能表型(El-Brolosy等人。, 2019)。诱导型表达系统是组成型表达的首选替代方案,使研究人员能够打开和关闭基因或滴定基因表达水平,更少的副作用和更高的效率。这种条件表达式的一个优点是能够以定量、时间调节和可逆的方式调节基因表达准确地揭示给定遗传变化的直接结果。四环素控制算子包含 TRE 启动子的系统提供具有大诱导范围的可逆基因表达低浓度的对哺乳动物细胞无毒的药物。TRE 启动子包含一个修改的 Tet 响应元件由包含 19-bp 的 36-nt 序列的七个重复组成Tet 运算符序列 (TCCCTATCAGTGATAGAGA)。这个 Tet 响应元素被定位最小 CMV 启动子序列的上游,该序列缺少天然 CMV 中存在的增强子发起人。因此,TRE 启动子在不与四环素结合的情况下是沉默的反应性 rtTA3 调节蛋白。系统的进步优化了反向Tet反式激活剂 (rtTA) 成分可提高药物敏感性和活性,更重要的是,显示在没有四环素或强力霉素(DOX,四环素类似物)的情况下没有活性,从而减少系统泄漏(Zhou et al. , 2006; Yamada et al. , 2018)。尽管如此,应该指出的是四环素衍生的污染物通常存在于细胞培养血清中;这对 Tet 提出了挑战-基于系统,但这个问题可以通过使用不含四环素的血清来避免。慢病毒为促进诱导基因表达的建立提供了有效的载体在一个细胞内,特别是因为它们能够感染许多不同的分裂和非分裂细胞类型(Naldini等人,1996 年;Reiser等人,1996 年),使慢病毒系统成为引入外源基因进入难以转导的目标,如原代细胞。虽然慢病毒平台确实存在内源性基因破坏的风险,这里描述的系统包装了所有组件进入单个载体平台,以便每个细胞只需要一次病毒感染即可诱导 tet基因表达(图 1A)。这消除了对多种病毒感染的需要并限制了可能的随机基因组整合的数量,从而限制对细胞的脱靶效应的机会生理学(Connolly等人,2002 年)。组成型表达的 Neo/Venus 转导标记包含在系统中可以轻松富集转导的细胞群,也可以很容易用另一种选择标记(例如,任何抗生素或细胞表面标记)替换以优化适用于各种细胞类型和应用的系统。这不仅使系统高度易于处理,而且第三代慢病毒载体的开发,如 pSLIK (Shin et al ., 2006),它分离了将 HIV 的最小遗传元件分成三个质粒(pMDL 含有 gag 和 pol,pRSV 含有rev 蛋白和含有包膜蛋白的...


  • A small sustained increase in NOD1 abundance promotes ligand-independent inflammatory and oncogene transcriptional responses

    by Leah M. Rommereim, Ajay Suresh Akhade, Bhaskar Dutta, Carolyn Hutcheon, Nicolas W. Lounsbury, Clifford C. Rostomily, Ram Savan, Iain D. C. Fraser, Ronald N. Germain, Naeha Subramanian

    A disproportionately large response is induced by small increases in the abundance of a pathogen sensor.


  • Type 1 interferon-dependent repression of NLRC4 and iPLA2 licenses down-regulation of Salmonella flagellin inside macrophages

    by Ajay Suresh Akhade, Shaikh M. Atif, Bhavana S. Lakshmi, Neha Dikshit, Kelly T. Hughes, Ayub Qadri, Naeha Subramanian

    Significance: While the effect of bacterial molecules on the host immune system is well studied, how host factors affect the expression of bacterial molecules is less appreciated. Here we uncover the impact of inflammasome activation and type 1 interferon on the expression of bacterial flagellin. Flagellin induces NLRC4 inflammasome-mediated pyroptosis causing clearance of Salmonella . We show that inflammasome activation also produces lysophospholipids which increase flagellin expression by Salmonella early in infection. We further demonstrate that as infection progresses, type 1 IFN inhibits NLRC4 and lysophospholipid synthesis, resulting in down-regulation of flagellin expression, a phenotype that the pathogen switches to during establishment of in vivo infection. These findings unravel pathways for biphasic regulation of expression of flagellin, a key Salmonella effector.


  • Open Access

    Antibody-recruiting protein-catalyzed capture agents to combat antibiotic-resistant bacteria

    by Matthew N. Idso, Ajay Suresh Akhade, Mario L. Arrieta-Ortiz, Bert T. Lai, Vivek Srinivas, James P. Hopkins, Ana Oliveira Gomes, Naeha Subramanian, Nitin Baliga, James R. Heath

    Antibiotic resistant infections are projected to cause over 10 million deaths by 2050, yet the development of new antibiotics has slowed. This points to an urgent need for methodologies for the rapid development of antibiotics against emerging drug resistant pathogens. We report on a generalizable combined computational and synthetic approach, called antibody-recruiting protein-catalyzed capture agents (AR-PCCs), to address this challenge. We applied the combinatorial protein catalyzed capture agent (PCC) technology to identify macrocyclic peptide ligands against highly conserved surface protein epitopes of carbapenem-resistant Klebsiella pneumoniae, an opportunistic Gram-negative pathogen with drug resistant strains. Multi-omic data combined with bioinformatic analyses identified epitopes of the highly expressed MrkA surface protein of K. pneumoniae for targeting in PCC screens. The top-performing ligand exhibited high-affinity (EC50 ∼50 nM) to full-length MrkA, and selectively bound to MrkA-expressing K. pneumoniae, but not to other pathogenic bacterial species. AR-PCCs that bear a hapten moiety promoted antibody recruitment to K. pneumoniae, leading to enhanced phagocytosis and phagocytic killing by macrophages. The rapid development of this highly targeted antibiotic implies that the integrated computational and synthetic toolkit described here can be used for the accelerated production of antibiotics against drug resistant bacteria.


  • Open Access

    A sustained small increase in NOD1 expression promotes ligand-independent oncogenic activity

    by Leah M. Rommereim, Ajay Suresh Akhade, Bhaskar Dutta, Carolyn Hutcheon, Nicolas W. Lounsbury, Clifford C. Rostomily, Ram Savan, Iain D. C. Fraser, Ronald N. Germain, Naeha Subramanian

    Small genetically-determined differences in transcription (eQTLs) are implicated in complex disease but the mechanisms by which small changes in gene expression impact complex disease are unknown. Here we show that a persistent small increase in expression of the innate sensor NOD1 precipitates large cancer-promoting changes in cell state. A ~1.2-1.4 fold increase in NOD1 protein concentration by loss of miR-15b/16 regulation sensitizes cells to ligand-induced inflammation, with an additional slight increase leading to ligand-independent NOD1 activation that is linked to poor prognosis in gastric cancer. Our data show that tight expression regulation of NOD1 prevents this sensor from exceeding a physiological switching checkpoint that promotes persistent inflammation and oncogene expression and reveal the impact of a single small quantitative change in cell state on cancer. One Sentence Summary: A small change in NOD1 expression has a large cancer-promoting impact on cell state.

  • NAGging Hexokinase PEPs up NLRP3

    by Henry Hampton, Carolyn Hutcheon, Naeha Subramanian


  • Cytoplasmic Sensing in Innate Immunity

    by C. Hutcheon, P. Paulvannan, N. Subramanian


  • AIMing 2 Curtail Cancer

    by Leah M. Rommereim, Naeha Subramanian